Abstract
The extracts and the compounds isolated from Phyllanthus amarus Schumm and Thonn
(Family: Euphorbiaceae) have shown a wide spectrum of pharmacological activities including
antiviral, antibacterial, antiplasmodial, antimalarial, antimicrobial, anticancer, antidiabetic,
hypolipidemic, antioxidant, hepatoprotective, nephroprotective and diurectic properties.
Background: This investigation was aimed at exploring the anxiolytic potential of Phyllanthus
amarus standardized extracts and predict probable role of marker phyto constitutents.
Objective and Methods: Three standardized extracts of Phyllanthus amarus plant viz. standardized
aqueous extract of Phyllanthus amarus whole plant (PAAE), standardized methanolic extract of P.
amarus leaf (PAME) and the standardized hydro-methanolic extract of P. amarus leaf (PAHME)
were tested in the classical animal models of anxiety: Elevated plus-maze model and Light & Dark
Exploration test.
Results: The lower doses of the tannin rich extract (PAHME) of the P. amarus possess significant
anxiolytic activity compared to lignin rich (PAME) and aqueous extracts (PAAE), while at a
higher dose (400mg/kg) the results of all three extracts appears to be potentially sedative. While
the molecular docking studies support these probable anxiolytic, the sedative effects of the
Phyllanthus amarus extracts could be due to the interaction of tannins and lignans with the GABAbenzodiazepine
receptor complex.
Conclusion: The results of the present study indicate that the tannin-rich extract of the P. amarus
may have potential clinical applications in the management of anxiety. It can be further studied for
optimum dosage to be used as a future of anti-anxiety drug development or as a standardized
Phytomedicine.
Keywords:
Phyllanthus amarus, anxiety, phyllanthin, hypophyllanthin, corilagin, lignans.
[2]
Seligman, M.E.; Walker, E.F.; Rosenhan, D.L. Abnormal psychology, 4th ed; W.W. Norton & Company: New York, 2000.
[3]
Nuckols, C.C.; Nuckols, C.C. The Diagnostic and Statistical Manual of Mental Disorders, (DSM-5); American Psychiatric Association: Philadelphia, 2013.
[16]
Pellow, S.; Chopin, P.; File, S.E.; Briley, M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 1985, 14(3), 149-167.
[18]
] Vallabh Prakashan, 3rd ed; Kulkarni, S.K. Hand Book of Experimental PharmacologyReprints, 2005, pp. 36-38.
[22]
Olabiyi, F.A.; Aboua, Y.G.; Popoola, O.K.; Monsees, T.K.; Oguntibeju, O.O. Evaluation of Antioxidant, Antityrosinase Activities and Cytotoxic Effects of Phyllanthus amarus Extracts. J. Nat. Prod., 2020, 10(2), 130-138.
[24]
Pinkaew, D.; Kiattisin, K.; Wonglangka, K.; Awoot, P. Efficacy and Safety of Phyllanthus Amarus Cream Treatment in Knee Osteoarthritis. Open Sports Sci. J., 2020, 12(1)
[25]
Pham, H.N.T.; Bowyer, M.C.; van Altena, I.A.; Scarlett, C.J. Influence of solvents and novel extraction methods on bioactive compounds and antioxidant capacity of Phyllanthus amarus. Chem. Pap., 2016, 70(5), 556-566.
[30]
Aman, U.; Subhan, F.; Shahid, M.; Akbar, S.; Ahmad, N.; Ali, G.; Fawad, K.; Sewell, R.D. Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms. BMC Compl. Alt. Med., 2016, 16(1), 77.
[35]
Meena, J.; Sharma, R.A.; Rolania, R. A review on phytochemical and pharmacological properties of Phyllanthus amarusSchum. and Thonn. Int. J. Pharm. Sci. Res., 2018, 9(4), 1377-1386.
[52]
Jadhav, B.S.; Yamgar, R.S.; Kenny, R.S.; Mali, S.N.; Chaudhari, H.K.; Mandewale, M.C. Synthesis and In-silico identification of new bioactive 1,3,4-oxadiazole tagged 2,3-dihydroimidazo[1,2- a]pyridine derivatives. Curr. Bioact. Compd., 2020. (accepted manuscript).
[53]
Thorat, B.R.; Mali, S.N.; Dalvi, B. Green Synthesis of Substituted dihydropyrimidin-2(1H)-one by using Zinc Chloride/acetic acid Catalytic System. Current Chinese Chemistry; Accepted Manuscript, 2020.
[54]
Thorat, BR.; Mali, SN.; Chopade, A. A Viewpoint on Angiotensin- Converting Enzyme 2, Anti-Hypertensives and Coronavirus
Disease 2019 (COVID-19). Infect. Disord. Drug Targets., 2020.(Accepted Manuscript).